Premenstrual Dysphoric Disorder Completed Phase 4 Trials for Paroxetine (DB00715)

Also known as: Premenstrual dysphoric disorder

IndicationStatusPhase
DBCOND0005024 (Premenstrual Dysphoric Disorder)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00516113A Placebo-Controlled Study to Investigate the Onset of Action of Paroxetine in Premenstrual DysphoriaTreatment